Pharmaceutical Technology Europe-05-01-2010

Testing the dissolution rates of a pharmaceutical formulation (also known as in vitro availability) aids drug quality control and is a compulsory requirement of the British, European and US pharmacopoeias.

A round up of news from across the globe.

Though many advantages are associated with the European Clinical Trials Directive, complexities have emerged since its introduction in 2004. Since 2007, efforts have been made to raise the issues and address the negative impact of the Directive.

Why spray drying processes offer a range of particle engineering possibilities.

The author assesses the power and limitations of NIR chemical imaging and its future.

Though the pharma industry has improved its change management processes, there are still opportunities for improvement.

Bioanalysis has migrated from a very general vocation to one that requires more specialization, particularly in GLP applications.

Advances in dissolution testing technology have been one of the biggest breakthroughs in solid dosage form testing over the last decade.

The needs of the pharmaceutical industry for powder testing technologies are changing, primarily for two reasons.

Over the last few months, we have been publishing a series of special features, which have sought to provide you with an overall view of current challenges, innovations and trends in niche pockets of the pharmaceutical industry.

The emerging markets represent an attractive investment opportunity for the pharmaceutical industry because of the countries' growing economies and unmet medical needs.

Lilly faces up to the new realities of the bio/pharmaceutical industry by embracing outsourcing.

The pharmaceutical industry must understand its responsibilities to improve the safety of chemicals as defined by the REACH initiative.